Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Citius Pharmaceuticals, Inc. | Vice Chairman, Director | Common Stock | 1.99M | $1.49M | $0.75 | Nov 7, 2024 | Direct |
Citius Pharmaceuticals, Inc. | Vice Chairman, Director | Stock Option (Right to Purchase Common Stock) | 350K | Nov 7, 2024 | Direct | ||
CITIUS ONCOLOGY, INC. | Secretary, Director | Stock Option (Right to Buy) | 300K | Dec 12, 2024 | Direct | ||
Citius Pharmaceuticals, Inc. | Vice Chairman, Director | Warrant to Purchase Common Stock | 129K | Nov 7, 2024 | Direct | ||
Citius Pharmaceuticals, Inc. | Vice Chairman, Director | Stock Option (Right to Buy) | 75K | Nov 7, 2024 | Indirect | ||
CITIUS ONCOLOGY, INC. | Secretary, Director | Stock Option (Right to Buy) | 50K | Dec 12, 2024 | Indirect | ||
ASSEMBLY BIOSCIENCES, INC. | Director | Stock Option (right to buy) | 15K | May 20, 2021 | Direct | ||
Citius Pharmaceuticals, Inc. | Vice Chairman, Director | Stock Option (Right to Purchase Common Stock) | 10K | Nov 7, 2024 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CTOR | CITIUS ONCOLOGY, INC. | Dec 12, 2024 | 2 | $0 | 4 | Dec 16, 2024 | Secretary, Director |
CTXR | Citius Pharmaceuticals, Inc. | Nov 7, 2024 | 2 | $0 | 4 | Nov 12, 2024 | Vice Chairman, Director |
CTXR | Citius Pharmaceuticals, Inc. | Aug 14, 2024 | 4 | $0 | 4 | Sep 27, 2024 | Vice Chairman, Director |
CTOR | CITIUS ONCOLOGY, INC. | Aug 12, 2024 | 1 | $0 | 4/A | Aug 30, 2024 | Director |
CTOR | CITIUS ONCOLOGY, INC. | Aug 12, 2024 | 0 | $0 | 3 | Aug 14, 2024 | Director |
CTXR | Citius Pharmaceuticals, Inc. | Apr 3, 2024 | 2 | $0 | 4 | Apr 5, 2024 | Vice Chairman, Director |
CTXR | Citius Pharmaceuticals, Inc. | Oct 10, 2023 | 1 | $0 | 4 | Oct 12, 2023 | Vice Chairman, Director |
CTXR | Citius Pharmaceuticals, Inc. | Oct 4, 2022 | 1 | $0 | 4 | Oct 6, 2022 | Vice Chairman, Director |
CTXR | Citius Pharmaceuticals, Inc. | Oct 11, 2021 | 2 | $0 | 4 | Oct 13, 2021 | President and CEO, Director |
CTXR | Citius Pharmaceuticals, Inc. | Jul 22, 2021 | 2 | $0 | 4 | Jul 26, 2021 | President and CEO, Director, 10%+ Owner |
ASMB | ASSEMBLY BIOSCIENCES, INC. | May 20, 2021 | 1 | $0 | 4 | May 24, 2021 | Director |